Literature DB >> 23456951

National Institute on Drug Abuse symposium report: drugs of abuse, dopamine, and HIV-associated neurocognitive disorders/HIV-associated dementia.

Vishnudutt Purohit1, Rao Rapaka, Jerry Frankenheim, Albert Avila, Roger Sorensen, Joni Rutter.   

Abstract

The National Institute on Drug Abuse organized a symposium on drugs of abuse, dopamine, and HIV-associated neurocognitive disorders (HAND)/HIV-associated dementia (HAD) in Rockville, Maryland, October 4, 2011. The purpose of this symposium was to evaluate the potential role of dopamine in the potentiation of HAND/HAD by drugs of abuse. A summary of the symposium has been presented in this report.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23456951     DOI： 10.1007/s13365-013-0153-2

Source DB:  PubMed          Journal:  J Neurovirol        ISSN： 1355-0284            Impact factor:   2.643


  15 in total

1.  Enhancement of central nervous system pathology in early simian immunodeficiency virus infection by dopaminergic drugs.

Authors:  S Czub; E Koutsilieri; S Sopper; M Czub; C Stahl-Hennig; J G Müller; V Pedersen; W Gsell; J L Heeney; M Gerlach; G Gosztonyi; P Riederer; V ter Meulen
Journal:  Acta Neuropathol       Date:  2001-02       Impact factor: 17.088

2.  Dopamine activates HIV in chronically infected T lymphoblasts.

Authors:  C Scheller; S Sopper; C Jassoy; V ter Meulen; P Riederer; E Koutsilieri
Journal:  J Neural Transm (Vienna)       Date:  2000       Impact factor: 3.575

3.  Dopamine quinones activate microglia and induce a neurotoxic gene expression profile: relationship to methamphetamine-induced nerve ending damage.

Authors:  Donald M Kuhn; Dina M Francescutti-Verbeem; David M Thomas
Journal:  Ann N Y Acad Sci       Date:  2006-08       Impact factor: 5.691

4.  Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells.

Authors:  Madhavan P N Nair; Zainulabedin M Saiyed; Narayanan Nair; Nimisha H Gandhi; Jose W Rodriguez; Nawal Boukli; Elias Provencio-Vasquez; Robert M Malow; Maria Jose Miguez-Burbano
Journal:  J Neuroimmune Pharmacol       Date:  2008-10-29       Impact factor: 4.147

5.  Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains.

Authors:  Adarsh M Kumar; J B Fernandez; Elyse J Singer; Deborah Commins; Drenna Waldrop-Valverde; Raymond L Ownby; Mahendra Kumar
Journal:  J Neurovirol       Date:  2009-05       Impact factor: 2.643

6.  Decreased brain dopamine transporters are related to cognitive deficits in HIV patients with or without cocaine abuse.

Authors:  Linda Chang; Gene-Jack Wang; Nora D Volkow; Thomas Ernst; Frank Telang; Jean Logan; Joanna S Fowler
Journal:  Neuroimage       Date:  2008-05-20       Impact factor: 6.556

Review 7.  Methamphetamine toxicity and messengers of death.

Authors:  Irina N Krasnova; Jean Lud Cadet
Journal:  Brain Res Rev       Date:  2009-03-25

8.  Modulation of simian immunodeficiency virus neuropathology by dopaminergic drugs.

Authors:  S Czub; M Czub; E Koutsilieri; S Sopper; F Villinger; J G Müller; C Stahl-Hennig; P Riederer; V Ter Meulen; G Gosztonyi
Journal:  Acta Neuropathol       Date:  2004-01-08       Impact factor: 17.088

9.  Methamphetamine modulates DC-SIGN expression by mature dendritic cells.

Authors:  Madhavan P N Nair; Supriya Mahajan; Don Sykes; Meghana V Bapardekar; Jessica L Reynolds
Journal:  J Neuroimmune Pharmacol       Date:  2006-06-23       Impact factor: 4.147

10.  Characterization and function of the human macrophage dopaminergic system: implications for CNS disease and drug abuse.

Authors:  Peter J Gaskill; Loreto Carvallo; Eliseo A Eugenin; Joan W Berman
Journal:  J Neuroinflammation       Date:  2012-08-18       Impact factor: 8.322
View more
  7 in total

Review 1.  Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction.

Authors:  Laura L Giacometti; Jacqueline M Barker
Journal:  Brain Res       Date:  2019-08-14       Impact factor: 3.252

2.  HIV Tat excites D1 receptor-like expressing neurons from rat nucleus accumbens.

Authors:  G Cristina Brailoiu; Elena Deliu; Jeffrey L Barr; Linda M Console-Bram; Alexandra M Ciuciu; Mary E Abood; Ellen M Unterwald; Eugen Brailoiu
Journal:  Drug Alcohol Depend       Date:  2017-06-08       Impact factor: 4.492

3.  Self-reported sleep disturbance is associated with lower CD4 count and 24-h urinary dopamine levels in ethnic minority women living with HIV.

Authors:  Julia S Seay; Roger McIntosh; Erin M Fekete; Mary Ann Fletcher; Mahendra Kumar; Neil Schneiderman; Michael H Antoni
Journal:  Psychoneuroendocrinology       Date:  2013-07-10       Impact factor: 4.905

4.  Methamphetamine compromises gap junctional communication in astrocytes and neurons.

Authors:  Paul Castellano; Chisom Nwagbo; Luis R Martinez; Eliseo A Eugenin
Journal:  J Neurochem       Date:  2016-04-18       Impact factor: 5.372

5.  No differences in delay discounting between smokers with and without HIV.

Authors:  Cory Czuczman; Morgan Thompson; E Paul Wileyto; Robert Schnoll; David Metzger; Frank Leone; Karam Mounzer; Robert Gross; Rebecca L Ashare
Journal:  Psychopharmacology (Berl)       Date:  2020-11-12       Impact factor: 4.530

Review 6.  The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders.

Authors:  Sonia Mediouni; Maria Cecilia Garibaldi Marcondes; Courtney Miller; Jay P McLaughlin; Susana T Valente
Journal:  Front Microbiol       Date:  2015-10-23       Impact factor: 5.640

7.  Altered White Matter Integrity in Human Immunodeficiency Virus-Associated Neurocognitive Disorder: A Tract-Based Spatial Statistics Study.

Authors:  Se Won Oh; Na-Young Shin; Jun Yong Choi; Seung-Koo Lee; Mi Rim Bang
Journal:  Korean J Radiol       Date:  2018-04-06       Impact factor: 3.500
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.